Related Experiment Videos
Hematopoietic growth factors: frontiers for cure
1Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, USA.
The Veterinary Clinics of North America. Small Animal Practice
|November 1, 1995
Summary
Hematopoietic growth factors, such as erythropoietin and interleukins, regulate blood cell development and show promise in veterinary medicine for improving patient quality of life and reducing treatment toxicity.
Area of Science:
- Veterinary Hematology
- Cytokine Biology
- Animal Therapeutics
Background:
- Hematopoietic growth factors are crucial cytokines controlling blood cell lineage growth, development, and function.
- These factors offer significant potential for enhancing patient well-being and mitigating treatment-related toxicities in clinical settings.
- Understanding their application in veterinary medicine is essential for advancing animal care.
Purpose of the Study:
- To review clinically relevant hematopoietic growth factors.
- To summarize current knowledge regarding their use in veterinary medicine.
- To highlight specific factors including erythropoietin, stem-cell factor, and various interleukins and colony-stimulating factors.
Main Methods:
- Literature review of existing studies and clinical data.
- Focus on hematopoietic growth factors with established clinical relevance.
- Analysis of their specific applications and outcomes in veterinary medicine.
Main Results:
- Erythropoietin, stem-cell factor, interleukin-3, interleukin-5, granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF), and macrophage colony-stimulating factor (M-CSF) are discussed.
- Evidence for their therapeutic potential in veterinary patients is examined.
- Current understanding of their efficacy and safety in animals is presented.
Conclusions:
- Hematopoietic growth factors have demonstrated potential in veterinary medicine.
- Further research and clinical application can improve treatment outcomes and reduce toxicity in animals.
- Key factors like EPO, SCF, IL-3, IL-5, GM-CSF, G-CSF, and M-CSF warrant continued investigation for veterinary use.